Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Bullboard - Stock Discussion Forum Biosyent Inc V.RX

Alternate Symbol(s): BIOYF

Healthcare

BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing... see more

Add To Watchlist

Bullboard (TSXV:RX)

View:

Post by overnouton Jul 29, 2024 3:25pm

Buyer

Wonder who bought 500,000 at $10?

Post by Farmer9on Jul 28, 2024 5:36pm

The next RX

RMB reminds me of RX of 17-18 years ago. Low share count and makes a profit.

105

Level Up Your Trading with BMO InvestorLine’s Enhanced Features

posted Nov 24, 2024 9:00am by Bank of Montreal

Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more

Comment by northernman59on Jul 25, 2024 8:49pm

RE:insider sale

AND?

Discussion

Post by Possibleidiot01on Jul 24, 2024 8:01pm

insider sale

FAX Capital Files Early Warning Report Regarding Disposition of Common Shares of BioSyent Inc. GlobeNewswireJul 24, 2024 7:36 PM EDT TORONTO, July 24, 2024 (GLOBE NEWSWIRE) -- This press ...more

162

Discussion

Post by FormerHedgieon Jul 05, 2024 11:55am

Zefenopril can double stock in 4 years @ 10% annual growth

KEY FINDINGS: Zefenopril can double RX's share price ($19.58) within 4 years of launch and has an NPV10 of $159M. After 10 years the share price could be $49. I wanted to do a bit more work ...more

201

Post by FormerHedgieon Jun 21, 2024 11:53am

63,200 first heart attacks / year in Canada

According to health Canada, 63,200 people in Canada have their first heart attacks each year in Canada https://www.canada.ca/en/public-health/services/publications/diseases-conditions/heart-disease ...more

111

Post by FormerHedgieon Jun 21, 2024 11:40am

Zofenopril has unique properties post heart attack (SMILE)

This is the first product announcment from RX that I am REALLY excited about and feel this can drive very meaningful share appreciation. I really like the theraputic profile of this drug and ...more

194

Comment by FormerHedgieon Jun 20, 2024 3:10pm

RE:RE:Think the endocrine drug is Zofenopril | high blood pressure

I don't think that comment precludes this. Hyper tension is a rapidly growing issue in the broader population. Typically, I have found that Canada does not usually have access to as broad a ...more

103

Discussion

Comment by lscfaon Jun 20, 2024 3:04pm

RE:RE:Think the endocrine drug is Zofenopril | high blood pressure

Medicines for endocrine disorders Adrenal hormones and synthetic substitutes Hydrocortisone (oral) Fludrocortisone (oral) Androgens Testosterone (IM) ...more

Discussion

Comment by lscfaon Jun 20, 2024 2:58pm

RE:Think the endocrine drug is Zofenopril | high blood pressure

I doubt its high blood pressure.... "We see a significant opportunity with this product which will address an unmet medical need in Canada.”

Discussion

Post by FormerHedgieon Jun 20, 2024 2:49pm

Think the endocrine drug is Zofenopril | high blood pressure

Based on the stocks reaction to this announcement I feel like some people know much more about this product and its potential then I do???? I found the press release cryptic (which I assume was done ...more

196

Discussion

Post by FormerHedgieon Jun 20, 2024 2:47pm

Does anyone have more information on the endocrine product??

110

(0)
•••

Post by PressReleaseon Jun 12, 2024 9:00am

New Press Release - BioSyent In-Licenses Endocrinology Product for Canada

MISSISSAUGA, Ontario, June 12, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc. (“BioSyent Pharma”), has entered into an agreement with a European partner for an exclusive license to...read article.

Comment by northernman59on May 28, 2024 6:55pm

RE:RE:Thank you

Well said and I agree with your logic.going private is interesting but i would lose in the long run as really enjoy my retirement with dividends into tfsa.

Discussion

Comment by FormerHedgieon May 28, 2024 11:15am

RE:Thank you

I agree with your because I also bought it back then. The questions is, how long do you conitnue to hold the stock for with no growth over the past few years and no real plan for growth that I ...more

Discussion

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

< Previous

Next >

Dealroom for high-potential pre-IPO opportunities

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard - Stock Discussion Forum Biosyent Inc V.RX

Alternate Symbol(s): BIOYF

Join the community and start posting on the bullboards today. It's free.

Create a portfolio watchlist today. It's free.

Bullboard (TSXV:RX)